Taiwan - Delayed Quote TWD

Maywufa Company Ltd. (1731.TW)

22.90
+0.10
+(0.44%)
At close: May 9 at 1:30:21 PM GMT+8
Loading Chart for 1731.TW
  • Previous Close 22.80
  • Open 22.80
  • Bid 22.75 x --
  • Ask 22.95 x --
  • Day's Range 22.70 - 22.95
  • 52 Week Range 20.15 - 26.50
  • Volume 56,035
  • Avg. Volume 152,421
  • Market Cap (intraday) 3.05B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 18.17
  • EPS (TTM) 1.26
  • Earnings Date --
  • Forward Dividend & Yield 1.15 (5.02%)
  • Ex-Dividend Date Jun 28, 2024
  • 1y Target Est --

Maywufa Company Ltd. manufactures and sells hair and skin care products under the Maywufa brand in Taiwan. It engages in the manufacturing, processing, and distribution of hairdressing products, soap, and cosmetics; distribution, wholesale, and retail trading of various beauty products, health products, and sports equipment; retail and wholesale business of health food, such as vitamin pills and oral liquid nutrients; trading, wholesale, and retail of medical drugs and medical equipment; wholesale and retail sales of food, baby products, and general food products; and wholesale trading and agency business. The company also provides consulting and analysis; warehousing services; and mother and baby skin care products under the Mustela brand. In addition, the company provides pharmaceuticals and medical devices, such as PG2 Lyophilized injection for treatment of cancer-related fatigue; AmCad-UT Detection device, an ultrasound CAD for thyroid cancer detection; Bio-Three tablets for the treatment of mild diarrhea, abdominal pain, and constipation; and Cerebrolysin, a supplementary nutrient boost for patients who cannot ingest adequate food and patients who have difficulties in the digestion, absorption, synthesis, and utilization of proteins, as well as for patients suffering from severe trauma, burns, fractures, insufficient protein intake, or malnutrition. Maywufa Company Ltd. was founded in 1976 and is headquartered in Taipei, Taiwan.

www.maywufa.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 1731.TW

View More

Performance Overview: 1731.TW

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

1731.TW
0.00%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
9.20%

1-Year Return

1731.TW
4.00%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
1.72%

3-Year Return

1731.TW
38.81%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
30.32%

5-Year Return

1731.TW
109.19%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
91.86%

Compare To: 1731.TW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1731.TW

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    3.04B

  • Enterprise Value

    3.09B

  • Trailing P/E

    18.17

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.03

  • Price/Book (mrq)

    1.40

  • Enterprise Value/Revenue

    2.06

  • Enterprise Value/EBITDA

    11.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.23%

  • Return on Assets (ttm)

    4.00%

  • Return on Equity (ttm)

    7.86%

  • Revenue (ttm)

    1.5B

  • Net Income Avi to Common (ttm)

    168.47M

  • Diluted EPS (ttm)

    1.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    195.92M

  • Total Debt/Equity (mrq)

    29.37%

  • Levered Free Cash Flow (ttm)

    -466.14M

Research Analysis: 1731.TW

View More

Company Insights: 1731.TW

Research Reports: 1731.TW

View More

People Also Watch